TK216

· Oncternal Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TK216, covering 2024-11-07 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma [Phase 2]